Collegium Pharmaceutical (COLL) Goodwill (2022 - 2026)

Collegium Pharmaceutical's Goodwill history runs 5 years deep, the most recent figure standing at $145.9 million for Q1 2026.

• On a quarterly basis, Goodwill fell 3.21% year-over-year to $145.9 million in Q1 2026; TTM through Mar 2026 was $145.9 million, a 3.21% decrease from a year earlier, with the FY2025 full-year figure at $145.9 million, down 10.11% from the prior year.
• Goodwill steadied at $145.9 million in Q1 2026 per COLL's latest filing, from $145.9 million in the prior quarter.
• Across five years, Goodwill topped out at $162.3 million in Q4 2024 and bottomed at $130.1 million in Q2 2022.
• The 5-year median for Goodwill is $133.9 million (2023), against an average of $139.6 million.
• Across the five-year window, Goodwill advanced 21.27% in 2024 and retreated 10.11% in 2025, its largest moves.
• Year by year, Goodwill stood at $133.7 million in 2022, then increased by 0.12% to $133.9 million in 2023, then rose by 21.27% to $162.3 million in 2024, then declined by 10.11% to $145.9 million in 2025, then changed by 0.0% to $145.9 million in 2026.
• Per Business Quant, the three latest COLL Goodwill figures stand at $145.9 million (Q1 2026), $145.9 million (Q4 2025), and $145.9 million (Q3 2025).